Evidence map›Paper›PMID 38475490›Full record

ArticlePlants (Basel, Switzerland)2024

Identification of Hypoglycemic Glycolipids from

Daniel Rosas-Ramírez, Roberto Arreguín-Espinosa, Sonia Escandón-Rivera, Adolfo Andrade-Cetto, Gerardo Mata-Torres, Ricardo Pérez-Solís

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Daniel Rosas-RamírezDepartamento de Química de Biomacromoléculas, Instituto de Química, Universidad Nacional Autónoma de México, Av. Universidad 3000, Circuito Exterior s/n, Coyoacán, Ciudad Universitaria, Mexico City 04510, Mexico.ORCID 0000-0001-6076-2320
Roberto Arreguín-EspinosaDepartamento de Química de Biomacromoléculas, Instituto de Química, Universidad Nacional Autónoma de México, Av. Universidad 3000, Circuito Exterior s/n, Coyoacán, Ciudad Universitaria, Mexico City 04510, Mexico.ORCID 0000-0002-4611-4770
Sonia Escandón-RiveraDepartamento de Biología Celular, Facultad de Ciencias, Universidad Nacional Autónoma de México, Av. Universidad 3000, Circuito Exterior s/n, Coyoacán, Ciudad Universitaria, Mexico City 04510, Mexico.ORCID 0000-0001-7949-176X
Adolfo Andrade-CettoDepartamento de Biología Celular, Facultad de Ciencias, Universidad Nacional Autónoma de México, Av. Universidad 3000, Circuito Exterior s/n, Coyoacán, Ciudad Universitaria, Mexico City 04510, Mexico.ORCID 0000-0002-1638-3443
Gerardo Mata-TorresDepartamento de Biología Celular, Facultad de Ciencias, Universidad Nacional Autónoma de México, Av. Universidad 3000, Circuito Exterior s/n, Coyoacán, Ciudad Universitaria, Mexico City 04510, Mexico.ORCID 0000-0001-9183-5326
Ricardo Pérez-SolísDepartamento de Química de Biomacromoléculas, Instituto de Química, Universidad Nacional Autónoma de México, Av. Universidad 3000, Circuito Exterior s/n, Coyoacán, Ciudad Universitaria, Mexico City 04510, Mexico.ORCID 0000-0002-9212-1867
Universidad Nacional Autónoma de México · MXInstituto Tecnológico Superior de Xalapa · MX

Funding

Universidad Nacional Autónoma de México IN213222Universidad Nacional Autónoma de México IN215823
6 · The paper itself

Abstract

In the pursuit of identifying the novel resin glycoside modulators glucose-6-phosphatase and

Indexed as

dynamic light scatteringglucose-6-phosphatase inhibitorglycolipidsIpomoea murucoidesmolecular dockingresin glycosidesα-glucosidase inhibitor

Identifiers

PMID38475490
PMCPMC10934653
OpenAlexW4392155288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.